Telephone
N/A
Address
107 Rundle Street Kent Town, South Australia (SA) 5067
Description
Nova Eye Medical Ltd. engages in developing suite of novel ophthalmic treatment technologies. It operates through the following segments: Faster Growing (iTrack), Emerging (2RT), and Core Ophthalmic Mark (Lasers and Ultrasounds). The iTrack segment offers catheter device that dilates the ocular structures compromised by glaucoma. The 2RT segment includes patent-protected with significant lead on competition and a per-use recurring fee business model. The Lasers and Ultrasounds segment represents testimony to the strength of the Ellex brand and was driven by growth in sales of the high-margin Ellex Tango and Ellex Tango Reflex glaucoma lasers. The company was founded by Giuseppe Canala and Victor Previn in 1985 and is headquartered in Kent Town, Australia.
Market Cap
PE
EV/EBITDA
DIV Yield
Franking
Ex Dividend Date (est.)
52 weeks range
Low 0.12 - 0.35
Trade Value (12mth)
AU$16,917.00
1 week
0%
1 month
-23.53%
YTD
-57.38%
1 year
-53.57%
All time high
0.731613
EPS 3 yr Growth
101.400%
EBITDA Margin
-56.10%
Operating Cashflow
-$7m
Free Cash Flow Return
-24.10%
ROIC
-54.70%
Interest Coverage
-176.90
Quick Ratio
1.70
Shares on Issue (Fully Dilluted)
165m
HALO Sector
Healthcare
Next Company Report Date
28-Aug-24
Ex Dividend Date (est.)
N/A
Next Dividend Pay Date (est.)
N/A
Reporting Currency
AUD
Short Sell (% of issue)
0.00
Date | Announcements |
---|---|
31 March 23 |
FDA Clears iTrack Advance for US Launch
×
FDA Clears iTrack Advance for US Launch |
31 March 22 |
EYE Representative Appointed to American Glaucoma Society
×
EYE Representative Appointed to American Glaucoma Society |
31 August 20 |
FY20 Results presentation
×
FY20 Results presentation |
30 October 23 |
Proposed USA Medicare Changes
×
Proposed USA Medicare Changes |
30 January 23 |
Glaucoma Surgical Devices Sales Update
×
Glaucoma Surgical Devices Sales Update |
28 November 23 |
Further Update of Proposed USA Medicare Changes
×
Further Update of Proposed USA Medicare Changes |
28 March 23 |
Notice Of General Meeting
×
Notice Of General Meeting |
28 February 22 |
Notification regarding unquoted securities - EYE
×
Notification regarding unquoted securities - EYE |
28 August 23 |
Appendix 4E and Annual Report
×
Appendix 4E and Annual Report |
28 August 23 |
Full Year Financial Results
×
Full Year Financial Results |
28 August 23 |
Appendix 4G
×
Appendix 4G |
28 August 23 |
Investor Presentation 30 June 2023 Results
×
Investor Presentation 30 June 2023 Results |
28 April 23 |
Results of General Meeting
×
Results of General Meeting |
27 October 23 |
Pause in Trading
×
Pause in Trading |
27 October 23 |
Trading Halt
×
Trading Halt |
27 November 20 |
AGM presentation and update
×
AGM presentation and update |
27 July 23 |
Application for quotation of securities - EYE
×
Application for quotation of securities - EYE |
27 January 23 |
Notification of cessation of securities - EYE
×
Notification of cessation of securities - EYE |
27 February 23 |
Trading Halt
×
Trading Halt |
26 October 20 |
Notice of Annual General Meeting/Proxy Form
×
Notice of Annual General Meeting/Proxy Form |
26 August 22 |
Appendix 4E and Annual Report FY22
×
Appendix 4E and Annual Report FY22 |
26 August 22 |
Results Announcement FY22
×
Results Announcement FY22 |
26 August 22 |
Investor Presentation FY22
×
Investor Presentation FY22 |
26 August 22 |
Appendix 4G and Corporate Governance Statement
×
Appendix 4G and Corporate Governance Statement |
25 September 23 |
AGM date and Closing Date for Director Nominations
×
AGM date and Closing Date for Director Nominations |
25 October 23 |
Angle Closure Glaucoma
×
Angle Closure Glaucoma |
25 November 22 |
Application for quotation of securities - EYE
×
Application for quotation of securities - EYE |
25 May 22 |
Notification regarding unquoted securities - EYE
×
Notification regarding unquoted securities - EYE |
Load More
Load Less
Historical data
Forecasted data
Load More
Load Less
Historical data
Forecasted data
Load More
Load Less
Historical data
Forecasted data
Load More
Load Less
Percent of Issue
Value ($M)
Prior Change
7 Day Change
1 Month Change
3 Month Change
Access data on short interest, stock performance, and potential short-selling candidates across various markets to make informed decisions and optimize your trading strategies.
Unlock true investor intelligence
Research, trade and manage global markets from one place with HALO Global. It’s trading - the way you want it.
Get the latest insights and hot tips delivered right to your inbox
HALO Technologies Pty Ltd ABN 54 623 830 866 is a Corporate Authorised Representative No 1261916 of Macrovue Pty Ltd ABN 98 600 022 679 AFSL 484264. Macrovue Pty Ltd is a wholly owned subsidiary of HALO Technologies Pty Ltd.